1,180
Total Claims
$1.3M
Drug Cost
375
Beneficiaries
$3,582
Cost/Patient
Peer Comparison vs. 13,928 Gastroenterology providers
+83%
Cost per patient vs peers
$3,582 vs $1,956 avg
+116%
Brand preference vs peers
31.1% vs 14.4% avg
Opioid Prescribing
0.9%
Opioid Rate
11
Opioid Claims
$210
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
69% generic
Brand: 367 claims · $1.3M
Generic: 813 claims · $42K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Adalimumab | 12 | $182K |
| Glecaprevir/Pibrentasvir | 11 | $156K |
| Rifaximin | 38 | $113K |
| Adalimumab | 11 | $82K |
| Linaclotide | 76 | $70K |
| Prucalopride Succinate | 26 | $17K |
| Colestipol Hcl | 80 | $8,803 |
| Mesalamine | 12 | $8,183 |
| Lipase/Protease/Amylase | 11 | $7,726 |
| Pantoprazole Sodium | 240 | $5,236 |
| Lubiprostone | 52 | $4,700 |
| Sucralfate | 49 | $2,653 |
| Peg3350/Sod Sulf,bicarb,cl/Kcl | 121 | $1,887 |
| Diphenoxylate Hcl/Atropine | 33 | $1,516 |
| Nadolol | 13 | $1,092 |
Prescribing Profile
20
Unique Drugs
Patient Profile
68
Avg Age
58%
Female
1.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About